Water → 4-[5-(5-Chloro-6-isobutoxypyridin-3-yl)-1,2,4-oxadiazol-3-yl]-2-fluorobenzoic acid
反応式
C[Si]([N-][Si](C)(C)C)(C)C.[Li+].[Cl:11][C:12]1[CH:13]=[C:14]([C:19]2[O:23][N:22]=[C:21]([C:24]3[CH:33]=[CH:32][C:27]([C:28]([O:30]C)=[O:29])=[C:26]([F:34])[CH:25]=3)[N:20]=2)[CH:15]=[N:16][C:17]=1Cl.[OH2:35]>CC(C)CO.C1COCC1.CCOC(C)=O>[Cl:11][C:12]1[CH:13]=[C:14]([C:19]2[O:23][N:22]=[C:21]([C:24]3[CH:33]=[CH:32][C:27]([C:28]([OH:30])=[O:29])=[C:26]([F:34])[CH:25]=3)[N:20]=2)[CH:15]=[N:16][C:17]=1[O:35][CH2:13][CH:14]([CH3:19])[CH3:15]参加物
反応物 3
生成物 1
試薬・触媒・溶媒 3
実験手順
Lithium bis(trimethylsilyl)amide (700 μL; 1 M; 0.70 mmol) was added to a solution of methyl 4-[5-(5,6-dichloropyridin-3-yl)-1,2,4-oxadiazol-3-yl]-2-fluorobenzoate, obtained in step 1 (73.63 mg; 0.20 mmol) in 2-methyl-1-propanol (3 mL) and THF (2 mL). The resulting mixture was stirred at RT for 1 h. Water (500 uL) was added and the mixture was stirred at RT for 3 h, saponification was complete. The reaction mixture was then diluted with EtOAc and washed with HCl 1N, NaCl sat. solution and dried over magnesium sulfate. After evaporation of the solvents, the crude was purified by HPLC prep to afford the title compound as a slightly yellow powder. 1H NMR (DMSO-d6, 300 MHz) δ 8.94 (d, J=2.2 Hz, 1H), 8.60 (d, J=2.2 Hz, 1H), 8.08 (t, J=7.7 Hz, 1H), 8.01 (dd, J=8.1, 1.5 Hz, 1H), 7.94 (dd, J=11.1, 1.5 Hz, 1H), 4.27 (d, J=6.5 Hz, 2H), 2.16-2.07 (m, 1H), 1.01 (d, J=6.6 Hz, 6H). LC/MS (Method B): 390.3 (M−H)−, 392.2 (M+H)+. HPLC (Method A) Rt 5.49 min (Purity: 98.6%).
後処理
- stirringthe mixture was stirred at RT for 3 h
- washwashed with HCl 1N, NaCl sat. solution
- dry with materialdried over magnesium sulfate
- customAfter evaporation of the solvents
- customthe crude was purified by HPLC prep
出典と根拠
- ORDレコード
- ord-7d264019e5964879a7ee08dc51b2d1fb
- 出典データセット
- uspto-grants-2012_06
- 特許番号
- US08202865B2
反応ノート
読み込み中…